{"id":"https://openalex.org/W4252373133","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9025","title":"A prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma","display_name":"A prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma","publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W4252373133","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9025"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.9025","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9025","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.9025","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050528758","display_name":"Georgia Marie Beasley","orcid":"https://orcid.org/0000-0001-6387-9030","observed_orcids":["https://orcid.org/0000-0001-6387-9030"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Beasley","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071307352","display_name":"G. Sanders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Sanders","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021981756","display_name":"Jonathan S. Zager","orcid":"https://orcid.org/0000-0002-6886-4468","observed_orcids":["https://orcid.org/0000-0002-6886-4468"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. S. Zager","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014050503","display_name":"S. N. Hochwald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. N. Hochwald","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030021697","display_name":"S. Grobmyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Grobmyer","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032181259","display_name":"Robert H.I. Andtbacka","orcid":"https://orcid.org/0000-0002-4182-1126","observed_orcids":["https://orcid.org/0000-0002-4182-1126"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. H. Andtbacka","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081485182","display_name":"B. Peterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Peterson","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006360860","display_name":"W. Peters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. P. Peters","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032554893","display_name":"M. I. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. I. Ross","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079727911","display_name":"D. S. Tyler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. S. Tyler","raw_affiliation_strings":["Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, NC; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; University of Florida, Gainesville, FL; University of Utah, Salt Lake City, UT; Adherex Technologies, Inc., Durham, NC; M. D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I223532165","https://openalex.org/I3019308854","https://openalex.org/I33213144","https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"9025","last_page":"9025"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adh1","display_name":"ADH1","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cyclic-pentapeptide","display_name":"cyclic pentapeptide","score":0.7760000228881836},{"id":"https://openalex.org/keywords/n-cadherin","display_name":"N-cadherin","score":0.8730000257492065},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.7300000190734863},{"id":"https://openalex.org/keywords/isolated-limb-infusion","display_name":"isolated limb infusion","score":0.9940000176429749},{"id":"https://openalex.org/keywords/extremity-melanoma","display_name":"extremity melanoma","score":0.9290000200271606},{"id":"https://openalex.org/keywords/in-transit-melanoma","display_name":"in-transit melanoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6290000081062317},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/complete-response-rate","display_name":"complete response rate","score":0.6480000019073486},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.4059999883174896},{"id":"https://openalex.org/keywords/limb-salvage","display_name":"limb salvage","score":0.3059999942779541},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.4429999887943268},{"id":"https://openalex.org/keywords/pulmonary-toxicity","display_name":"pulmonary toxicity","score":0.3140000104904175},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9394083023071289},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.7108878493309021},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6776660680770874},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4924958646297455},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.49160534143447876},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.48165738582611084},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4587351381778717},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.42827099561691284},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.42411452531814575},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41339921951293945},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.38694149255752563},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3688462972640991},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.31791824102401733},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2819727659225464},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.9025","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.9025","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.9025","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2168228799","https://openalex.org/W4254442676","https://openalex.org/W2144340025","https://openalex.org/W2803188486","https://openalex.org/W4240979892","https://openalex.org/W1965951004","https://openalex.org/W1810160594","https://openalex.org/W2171180523","https://openalex.org/W2072088428","https://openalex.org/W1998402899"],"abstract_inverted_index":{"9025^":[0],"Background:":[1],"ILI":[2,257,263],"with":[3,19,23,51,67,79,282,333,556,589,594],"melphalan":[4,53],"dosing":[5],"corrected":[6,96],"for":[7,17,97,144,304,354,488,577],"ideal":[8],"body":[9],"weight":[10],"(IBW)":[11],"is":[12,34,250,517,528,545],"a":[13,35,48,63,172,267,301,316,474,518,523,532,595],"well":[14,280],"tolerated":[15,281],"treatment":[16,278,536],"patients":[18,76,130,140,179],"in-transit":[20],"extremity":[21,74],"melanoma":[22,75,306],"an":[24,271,501,509,585],"approximate":[25],"30%":[26],"CR":[27,283],"and":[28,58,88,104,161,170,236,284,311,329,350,366,373,376,378,394,415,552,581,614],"44%":[29],"overall":[30],"response":[31,120],"rate.":[32],"ADH-1":[33,43,82],"cyclic":[36],"pentapeptide":[37],"that":[38,287,446,506,512],"disrupts":[39],"N-cadherin":[40,105,209,298],"adhesion":[41],"complexes.":[42],"when":[44],"given":[45],"systemically":[46,84],"in":[47,62,90,212,270,315,490,522,539,547,562,587,599],"preclinical":[49],"model":[50],"regional":[52],"demonstrated":[54],"synergistic":[55],"antitumor":[56],"activity":[57],"had":[59],"minimal":[60],"toxicity":[61],"Phase":[64],"I":[65],"trial":[66,258],"M-ILI.":[68],"Methods:AJCC":[69],"stage":[70],"IIIB":[71],"or":[72,245,401,405,450,482,535,543],"IIIC":[73],"were":[77,108,131,241],"treated":[78],"4000mg":[80],"of":[81,175,196,214,326,341,371,380,388,427,464,531,560,565,611],"administered":[83],"on":[85,99,110,449,460],"Day":[86,100],"1":[87],"8":[89,178],"addition":[91],"to":[92,200,265,273,289,308,361,384,433,439],"standard":[93,294],"dose":[94],"M-ILI":[95,295],"IBW":[98],"1.":[101],"Drug":[102],"pK,":[103],"IHC":[106],"staining":[107],"performed":[109],"pretreatment":[111,217],"tumor":[112,218],"from":[113,293,572],"all":[114,434],"patients.":[115],"The":[116,165,277,424],"primary":[117],"endpoint":[118],"was":[119,168,210,279],"at":[121,136,171,204],"12":[122,145,202],"weeks":[123],"determined":[124],"by":[125,337],"modified":[126],"RECIST.":[127],"Results:":[128],"46":[129],"enrolled":[132],"over":[133,183],"15":[134],"months":[135],"4":[137],"institutions.":[138],"Thirty-four":[139],"are":[141,511,570,592],"presently":[142],"evaluable":[143],"week":[146],"response.":[147],"In":[148,331],"field":[149],"responses":[150],"include":[151],"14":[152],"CRs":[153,182],"(41.2%%),":[154],"9":[155,189],"PRs":[156],"(26.5%),":[157],"5":[158],"SDs":[159],"(14.7%),":[160],"6":[162,184],"PDs":[163],"(17.6%).":[164],"OR":[166,285],"rate":[167],"67.7%":[169],"median":[173,205],"follow-up":[174,206],"30":[176],"weeks,":[177],"have":[180,190,582],"sustained":[181],"months.":[185],"Of":[186],"34":[187],"patients,":[188],"developed":[191],"disease":[192],"outside":[193],"the":[194,253,261,334,338,351,385,391,440,461,491,496,504,513,529,540,563,573,600,608,615],"region":[195],"infusion":[197],"(median":[198],"time":[199],"progression":[201],"weeks)":[203],"36":[207],"weeks.":[208],"detected":[211],"20":[213],"25":[215],"(80%)":[216],"samples.":[219],"Grade":[220],"IV":[221],"toxicities":[222],"included":[223],"CPK":[224],"elevation":[225],"(4),":[226],"neutropenia":[227],"(1),":[228,233,235],"acute":[229],"respiratory":[230],"distress":[231],"syndrome":[232],"pneumonitis":[234],"pulmonary":[237],"infiltrate":[238],"(1).":[239],"There":[240],"no":[242],"limb":[243],"losses":[244],"compartment":[246],"syndromes.":[247],"Conclusions:This":[248],"study":[249,264],"not":[251],"only":[252],"first":[254,262],"prospective":[255],"multi-center":[256,319],"but":[259],"also":[260],"incorporate":[266],"targeted":[268],"agent":[269],"attempt":[272],"augment":[274],"anti-tumor":[275],"responses.":[276],"rates":[286],"appear":[288],"be":[290,398,486],"significantly":[291],"improved":[292],"alone.":[296],"Targeting":[297],"may":[299],"represent":[300],"novel":[302],"strategy":[303],"improving":[305],"sensitivity":[307],"chemotherapeutic":[309],"agents":[310],"warrants":[312],"further":[313],"investigation":[314],"large":[317],"randomized":[318],"trial.":[320],"[Table:":[321],"see":[322],"text]":[323],"ASCO":[324,339,359,386,425,497,609],"Conflict":[325,340,387,426,610],"Interest":[327,342,389,428,612],"Policy":[328,343,429,456,574,591,613],"Exceptions":[330],"compliance":[332],"guidelines":[335],"established":[336],"(J":[344,418,467],"Clin":[345,419,468],"Oncol.":[346,420,469],"2006":[347,421,470],"Jan":[348,422,471],"20;24[3]:519\u2013521)":[349],"Accreditation":[352],"Council":[353],"Continuing":[355],"Medical":[356],"Education":[357],"(ACCME),":[358],"strives":[360],"promote":[362],"balance,":[363],"independence,":[364],"objectivity,":[365],"scientific":[367],"rigor":[368],"through":[369],"disclosure":[370,430],"financial":[372,393,462],"other":[374,395,416],"interests,":[375],"identification":[377],"management":[379],"potential":[381],"conflicts.":[382],"According":[383],"Policy,":[390],"following":[392],"relationships":[396,463],"must":[397],"disclosed:":[399],"employment":[400],"leadership":[402],"position,":[403],"consultant":[404],"advisory":[406],"role,":[407],"stock":[408],"ownership,":[409],"honoraria,":[410],"research":[411,551],"funding,":[412],"expert":[413,521],"testimony,":[414],"remuneration":[417],"20;24[3]:520).":[423],"requirements":[431],"apply":[432],"authors":[435,579],"who":[436],"submit":[437],"abstracts":[438],"Annual":[441,493,601],"Meeting.":[442],"For":[443,604],"clinical":[444,541,549,566],"trials":[445,569],"began":[447],"accrual":[448],"after":[451],"April":[452],"29,":[453],"2004,":[454],"ASCO's":[455,590],"places":[457],"some":[458],"restrictions":[459],"principal":[465,475,514],"investigators":[466],"20;24[3]:521).":[472],"If":[473],"investigator":[476,515],"holds":[477],"any":[478],"restricted":[479],"relationships,":[480],"his":[481],"her":[483],"abstract":[484],"will":[485],"ineligible":[487],"placement":[489],"2009":[492],"Meeting":[494,602],"unless":[495],"Ethics":[498],"Committee":[499],"grants":[500],"exception.":[502],"Among":[503],"circumstances":[505],"might":[507],"justify":[508],"exception":[510,586],"(1)":[516],"widely":[519],"acknowledged":[520],"particular":[524],"therapeutic":[525],"area;":[526],"(2)":[527],"inventor":[530],"unique":[533],"technology":[534],"being":[537],"evaluated":[538],"trial;":[542],"(3)":[544],"involved":[546],"international":[548,558],"oncology":[550],"has":[553],"acted":[554],"consistently":[555],"recognized":[557],"standards":[559],"ethics":[561],"conduct":[564],"research.":[567],"NIH-sponsored":[568],"exempt":[571],"restrictions.":[575],"Abstracts":[576],"which":[578],"requested":[580],"been":[583],"granted":[584],"accordance":[588],"designated":[593],"caret":[596],"symbol":[597],"(^)":[598],"Proceedings.":[603],"more":[605],"information":[606],"about":[607],"exceptions":[616],"process,":[617],"please":[618],"visit":[619],"www.asco.org/conflictofinterest":[620],".":[621]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-05-12T00:00:00"}